secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elanco Animal Health Inc (ELAN)
CIK:        0001739104
Form:       8-K
Filed at:   2025-11-03T23:59:59+00:00
Accession:  0001104659-25-105246
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elanco refinances $1.1B + €400M + $540M credit facilities; extends maturities
-----------------------------------------------------------------------------

- Amendment No. 3 to Credit Agreement signed Oct 31, 2025; refinances existing term loans.
- New $1.1B USD term loan B due 2032, €400M euro term loan A due 2029, $540M farm credit due 2032.
- Proceeds plus cash on hand used to repay all outstanding term loan B due 2027 and pay fees.
- Lenders include JPMorgan Chase as administrative agent; Wilmington Trust as collateral agent.
- Amendment also modifies certain covenants and terms of the credit agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739104/000110465925105246/0001104659-25-105246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739104/000110465925105246/tm2529998d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-105246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer